The Food and Drug Administration should step up efforts to create a unique device-identification system, according to a letter from the Advancing Patient Safety Coalition. The correspondence accuses the agency of taking “an unreasonable amount of time” to address the issue, despite a 2007 law requiring such action. A unique device identification system would make it easier for health officials to track product recalls, the letter adds.
Please login or register first to view this content.